Das M - Search Results

1

[¹⁸F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy.

Levi J, Das M, Vasanawala MS, Behl D, Pomper M, Forde PM, Nakajima E, Sayre J, Shen B, Cabrera H, Del Mar N, Gullen M, Pierini M, Cox L, Lokre O, Perk T, Chae HD. Levi J, et al. Among authors: das m. J Nucl Med. 2024 Oct 24:jnumed.124.268253. doi: 10.2967/jnumed.124.268253. Online ahead of print. J Nucl Med. 2024. PMID: 39448270

2

Are We Getting Closer to the Promise of Cure? New Progress and Future Directions in the Treatment of Early-Stage Non-Small-Cell Lung Cancer.

Das M. Das M. JCO Oncol Pract. 2023 Jul;19(7):384-386. doi: 10.1200/OP.23.00170. Epub 2023 Apr 28. JCO Oncol Pract. 2023. PMID: 37116106

3

Advances in the Treatment of Stage III Non-Small Cell Lung Cancer.

Myall NJ, Das M. Myall NJ, et al. Among authors: das m. Clin Chest Med. 2020 Jun;41(2):211-222. doi: 10.1016/j.ccm.2020.02.008. Clin Chest Med. 2020. PMID: 32402357 Review.

4

Small Cell Lung Cancer: Emerging Targets and Strategies for Precision Therapy.

Patel SR, Das M. Patel SR, et al. Among authors: das m. Cancers (Basel). 2023 Aug 8;15(16):4016. doi: 10.3390/cancers15164016. Cancers (Basel). 2023. PMID: 37627044 Free PMC article. Review.

5

Diagnosis and Treatment of Adenocarcinomas and Squamous Cell Carcinomas of the Lung.

Das M, Tisch AH. Das M, et al. J Adv Pract Oncol. 2017 Apr;8(3):267-272. Epub 2017 Apr 1. J Adv Pract Oncol. 2017. PMID: 29928550 Free PMC article. Review.

6

Novel immunotherapy combinations in neoadjuvant non-small cell lung cancer (NSCLC): a better chance at cure?

Salter AI, Das M. Salter AI, et al. Among authors: das m. Transl Lung Cancer Res. 2024 Mar 29;13(3):673-677. doi: 10.21037/tlcr-23-735. Epub 2024 Mar 15. Transl Lung Cancer Res. 2024. PMID: 38601451 Free PMC article. No abstract available.

7

The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer.

Wu JT, Corrigan J, Su C, Dumontier C, La J, Khan A, Arya S, Harris AHS, Backhus L, Das M, Do NV, Brophy MT, Han SS, Kelley M, Fillmore NR. Wu JT, et al. Among authors: das m. Cancer Immunol Immunother. 2024 Jul 2;73(9):172. doi: 10.1007/s00262-024-03763-w. Cancer Immunol Immunother. 2024. PMID: 38954019 Free PMC article.

8

ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy.

Das M, Riess JW, Frankel P, Schwartz E, Bennis R, Hsieh HB, Liu X, Ly JC, Zhou L, Nieva JJ, Wakelee HA, Bruce RH. Das M, et al. Lung Cancer. 2012 Aug;77(2):421-6. doi: 10.1016/j.lungcan.2012.04.005. Epub 2012 May 1. Lung Cancer. 2012. PMID: 22555222

9

Angiogenesis and lung cancer: ramucirumab prolongs survival in 2(nd)-line metastatic NSCLC.

Das M, Wakelee H. Das M, et al. Transl Lung Cancer Res. 2014 Dec;3(6):397-9. doi: 10.3978/j.issn.2218-6751.2014.09.05. Transl Lung Cancer Res. 2014. PMID: 25806332 Free PMC article.

10

Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancer.

Das M, Donington JS, Murphy J, Kozak M, Eclov N, Whyte RI, Hoang CD, Zhou L, Le QT, Loo BW, Wakelee H. Das M, et al. Clin Lung Cancer. 2011 Sep;12(5):280-5. doi: 10.1016/j.cllc.2011.06.003. Epub 2011 Jul 14. Clin Lung Cancer. 2011. PMID: 21752720 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,876 results

Search Page

Filters